Treating cognitive impairment with transcranial low level laser therapy

Area of Science:

• Neuroscience
• Biomedical Engineering
• Gerontology

Background:

• Cognitive impairment in aging is linked to neuronal energy deficits and brain hypoperfusion.
• Vascular risk factors can exacerbate age-related cognitive decline.
• Low Level Laser Therapy (LLLT) has a history of use in various medical conditions.

Purpose of the Study:

• To examine the potential of transcranial LLLT using red or near-infrared wavelengths.
• To investigate LLLT's effects on brain cell function and neurometabolic pathways.
• To explore LLLT for preventing and treating cognitive impairment.

Main Methods:

• Application of red or near-infrared wavelengths transcranially.
• Utilizing LLLT to stimulate neuronal mitochondria.
• Review of existing clinical studies on LLLT and cognitive function.

Main Results:

• Recent clinical studies indicate LLLT can increase neurometabolic energy levels.
• LLLT may improve cerebral hemodynamics and cognitive abilities.
• Evidence suggests LLLT can boost neurometabolic activity.

Conclusions:

• Transcranial LLLT offers a potential non-invasive method to address age-related cognitive decline.
• This approach may help prevent or delay dementia, including Alzheimer's and vascular dementia.
• Advancements in LLLT technology signal a new era for treating neurocognitive disorders.